Matches in Nanopublications for { ?s ?p "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220692.RAEGt58RJ6S6_yIxORD9SXvbLewD5tpHXaDPiK4Pz8WYI130_assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220692.RAEGt58RJ6S6_yIxORD9SXvbLewD5tpHXaDPiK4Pz8WYI130_provenance.
- assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP978473.RAvAI7pC0Uvdi1GTf5IF59g3z3CLEHgwTC4M4ZWNcin8s130_assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978473.RAvAI7pC0Uvdi1GTf5IF59g3z3CLEHgwTC4M4ZWNcin8s130_provenance.
- NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1074748.RAED-5uHytPRL0YoQPqqDLXMJUf25GXVqVipcj88Pr_UM130_provenance.
- NP1074747.RAwPlPo3E_Bl6-jH-4xT_Xa8Ba6YLVYeOjxc3qkAzF0a8130_assertion description "[In particular, we focus on the role of loss-of-function mutations in TET2, gain-of-function mutations in IDH1 and IDH2, and loss-of-function mutations in ASXL1 and mutations of unclear impact in DNMT3A in AML pathogenesis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1074747.RAwPlPo3E_Bl6-jH-4xT_Xa8Ba6YLVYeOjxc3qkAzF0a8130_provenance.